Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

AA - Thoracic surgery > Cancer > Flashcards

Cancer Flashcards

1
Q

Incidence of Small cell lung cancer (SCLC)

A

15-25% of lung cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SCLC

A

chemo is primary treatment (Cisplatin, etoposide); surgery can rarely impact survival. Partial response to chemo may be amenable to surgery. Radiation is reserved for localized lesions without evidence of metastasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Radiation induced osteosarcoma. Radiologic and pathologic findings

A

Radiology: “sunburst”, periosteal reaction
Biopsy: malignant spindle cells, mitosis, and excess osteoid. Rib and sternum account for 5% of osteogenic sarcomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Radiation induced osteosarcoma rx

A

Neoadjuvant protocols. Complete wide local excision. Radiation is reserved for palliation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fleischner recommendations for < 4mm (Low risk and High risk pts)

A

Low risk: no follow up needed

High risk: F/u in 12 months. If unchanged, no further f/u

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fleischner recommendations for 4-6 mm (Low risk and High risk pts)

A

Low risk: F/u in 12 months, if unchanged, no further f/u

High risk: f/u in 6-12 mon, then 18-2 mo if no change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Fleischner recommendations for <6-8 mm (Low risk and High risk pts)

A

Low risk: f/u in 6-12 mo, then 18-24 mo if no change

High risk: CT at 3-6 mo, then 9-12 mo, and 24 months if no change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fleischner recommendations for >8 mm (Low risk and High risk pts)

A

Low risk: f/u CT at 3, 9, 24, dynamic contrast enhanced CT, PET, and/or biopsy
High risk: f/u CT at 3, 9, 24, dynamic contrast enhanced CT, PET, and/or biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What size nodule is a PET scan considered sensitive and specific

A

Purely solid lesion > 7 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

S/p pneumonectomy, c/o cough with serosanguineous sputum/hemoptysis, fever, CXR with air fluid level. Dx? Next step?

A

Post-pneumonectomy bronchopleural fistula with empyema. Next step is thoracentesis with culture –> chest tube placement –> bronchoscopy. Avoid bronchoscopy until pt is drained to minimize infection of the contralateral lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

S/p RU Lobectomy, fever + tachycardia 4 days later. CXR shows atelectactic middle lobe. Dx? Next Step?

A

Torsion of the lung. Next Step is flex bronch (will appear “fish mouth” on bronch) –> surgical emergency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors for lobar torsion (4)

A

division of inferior pulm ligament
failure to reexpand lung prior to closure
residual pneumothorax and pleural effusion
a remaining complete fissure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to avoid lobar torsion after lobectomy

A

Ensure remaining lobes are inflated in neutral and anatomic position
anchoring lung tissue at 2 points (the hilum and somewhere else (e.g. suturing or stapling middle lobe to the lower lobe)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

According to National Lung Screening Trial (NLST), what patient factors must be present to justify use of CT screening for lung cancer

A

age 55-74
> 30 pack year smoking
active smoker or quit < 15 years ago

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pt with SCC of RUL. Right hilar and level 4 lymph node with FDG avidity on PET, SUV (standardized uptake values) of 7 and 4, respectively. Next step?

A

EBUS with lymph node biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What value of SUV (standardized uptake values) is associated with high probability of malignancy

A

2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What factor affect the accuracy of SUB

A 
weight
blood glucose
leng of uptake period
partial volume effect
recovery coefficient
type of region of interest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

50 obese F with HTN and hirsutism, presented with hypokalemia, elevate urine/plasma cortisol and serum ACTH. MRI shows normal pituitary gland. CT shows LLL nodule. Whats the syndrome? Ddx? Next step?

A
  • Cushing syndrome
  • Ddx: bronchial carcinoid, islet cell cancer, small cell lung CA, medullary thyroid ca, neuroendocrine tumor, thymic carcinoid, pheochromocytoma, (of note, pituitary adenoma causing cushing syndrome is known as cushing disease)
  • next step: Somatostatin receptor scintigraphy with octreotide to identify hypersecreting tumors or FDG-PET
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Patient with resected stage III non-small cell lung cancer. Next step?

A

According to the LACE (lung adjuvant cisplatin evaluation) meta-analysis, adjuvant cisplatin-based chemotherapy had survival benefit over observation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Staging: any metastasis

A

At least stage IV-A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

T classification for tumor size < 1 cm

A

T1a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

T classification for tumor size 1-2 cm

A

T1b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

T classification for tumor size 2-3 cm

A

T1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T classification for tumor size 3-4 cm

A

T2a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
T classification for tumor size 4-5 cm
T2b
26
T classification for tumor size 5-7 cm
T3
27
T classification for tumor size >7 cm
T4
28
N1 nodes
ipsilateral, bronchopulmonary/hilar nodes (double digit, 10-15)
29
N2 noes
1-9 mediastinal nodes, subcarinal or ipsilateral internal mammary nodes
30
N0
No lymph node mets
31
N3
Contralateral mediastinal, internal mammary or hilar nodes or any subclavicular or scalene lymph nodes
32
Staging: N1 involvement
At the very least is a stage II B
33
Staging: T4, N0
Stage IIIA
34
Staging: T3, N1
Stage IIIA
35
Staging T2b, N0
Stage IIA (this is the only permutation of stage IIA)
36
Staging: T2a, N0
Stage I B (This is the only permutation of stage 1B)
37
Staging: T1, N0
Stage I A (subcategory of 1,2,3, based on tumor size)
38
Staging: T3, N2
Stage IIIB
39
Staging: T4, N2
Stage IIIB
40
Staging: T1, N3
Stage IIIB
41
Staging: T3, N3
Stage IIIC
42
Staging T1, N1
Stage IIB
43
Staging T1, N2
Stage IIIA
44
Staging: any N2 involvement
At least a stage IIIA
45
Staging: any N3 involvement
At least a stage IIIB
46
Findings of LACE meta analysis
Survival benefit for adjuvant cisplatin based chemo over observation in patients with resected stage II and III NSCLS.
47
Intergroup trial INT0139 findings
Patients with Stage IIIA (N2) disease had no significant difference in overall survival to chemorad with or without surgical resection. However, in an exploratory analysis, post-induction lobectomy had superior survival.
48
Management of pancoast tumor
According to the intergroup trial (INT 0160), treat with induction chemoradiation therapy, followed by complete resection including en-bloc chest wall resection, (may include subclavian vessels if involved)
49
Eligibility criteria for INT 0160
T3 or T4 superior sulcus tumors with either N0 or N1 disease, no distant metastasis
50
When is a sublobar resection oncologically sound?
Tumors <2cm in maximal diameter
51
T classification if tumor involves main bronchus (not carina), invades visceral pleura, or associated with atelectasis or obstructive pneumonitis that extends to the hilar region
T2a
52
T classification if tumor invades the parietal pleura and superior sulcus tumors, phrenic nerve, or parietal pericardium
T3
53
T classification if tumor is associated with a separate tumor nodule in a DIFFERENT ipsilateral lobe
T4
54
T classification if tumor is associated with a separate tumor nodule in the SAME ipsilateral lobe
T3
55
T classification if tumor involves with CARINA, diaphragm, mediastinum, heart, great vessels, trachia, recurrent largyneal nerve, esophagus, vertebra
T4
56
Patients with lung cancer with primary tumors > 4 cm or pos lymph nodes can be treated with?
adjuvant platinum-based chemo. This shows improved survival in a meta analysis of a large prospective randomized studies
57
Definition of R0 resection
Microscopically margin-negative resection
58
Definition of R1 resection
Indicates removal of all macroscopic disease, but microscopic margins are positive for tumor.
59
65F w/ T2N2 adenoCA and neoadj chemorads s/p RULobectomy. Post op, developed SOB, hypoxemia on PEEP 8. CXR with b/l fluffy infiltrate. Dx? Next step?
Post-resection pulmonary edema. Usually occurs after pneumonectomy, but may happen after lobectomy or sublobar resections. Tx: supportive. Ventilation with management analogous to tx of ARDS, i.e. high PEEP. If refractory, consider ECMO.
60
Risk factors for post op ARDS / post resection pulm edema. (10)
``` Older age Male Chronic suppurative lung disease reduced DLCO Low predicted post-op lung perfusion Prior irradiation or chemo Concurrent cardiac disease High blood loss/blood transfusion Excessive periop IVF Reoperation ```
61
Definition of persistent air leak per STS
Air leak that last for 5 days.
62
Risk factors for persistent air leak
COPD | Low preop lung function

AA - Thoracic surgery (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions